1. NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain
2. Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain
3. Department of Dentistry - Regenerative Biomaterials, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
4. Department of Health Technology, Institute of Biotherapeutic Engineering and Drug Targeting, Center for Intestinal Absorption and Transport of Biopharmaceuticals Technical University of Denmark, Lyngby, Denmark
5. Center for Minimally Invasive Therapeutics (C-MIT) Department of Radiological Sciences, University of California, Los Angeles, CA, USA
6. Department of Diagnostic and Public Health, Section of Pharmacology, University of Verona, Verona, Italy
7. Departments of Pharmaceutics, Chemical and Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA
8. Pathology and Medical Biology Section, Immunoendocrinology, University of Groningen, Groningen, The Netherlands
9. Gloriana Therapeutics, Inc. (Formerly NsGene Inc.), Providence, RI, USA
10. University Institute for Regenerative Medicine and Oral Implantology - UIRMI (Upv/ehu-fundación Eduardo Anitua), Vitoria, Spain
11. The Academia, Singapore Eye Research Institute, Discovery Tower, Singapore